Dog Testicular Cancer Neutering Welfare

Testicular tumors are the most common neoplasm in intact male dogs, with neutering providing both treatment and prevention of these welfare-significant cancers.

Key Facts

Testicular tumors affect approximately 7% of intact male dogs and are among the most common canine tumors
Three main tumor types occur: Sertoli cell tumors, seminomas, and interstitial cell tumors
Sertoli cell tumors can produce estrogen causing feminization syndrome and bone marrow suppression
The vast majority of testicular tumors are benign and cured by castration
Cryptorchid testicles (retained in the abdomen) have 10 times the normal tumor risk
Metastatic testicular cancer is rare but does occur, particularly with Sertoli cell tumors
Early castration prevents testicular cancer entirely

Welfare Considerations

Testicular tumors cause welfare harm through local mass effects, hormone-secreting tumors causing feminization and blood disorders, and the rare metastatic disease. Feminizing Sertoli cell tumors can cause severe bone marrow suppression leading to life-threatening anemia and bleeding disorders. Pain from large tumors is a welfare concern. For the vast majority of affected dogs, prompt castration is curative and the welfare outcome is excellent. Retained testicles should be removed prophylactically given the dramatically elevated tumor risk, as the welfare consequences of Sertoli cell tumors developing in retained testicles can be severe.

What You Can Do

Castrate cryptorchid male dogs promptly to prevent the high cancer risk associated with retained testicles
Monitor intact male dogs for testicular asymmetry, enlargement, or firmness indicating tumor development
Seek veterinary assessment for any testicular changes in intact male dogs
Consider neutering intact male dogs as a preventive measure for testicular cancer
Pursue prompt surgery for confirmed testicular tumors as the cure rate is excellent
Complete staging workup for Sertoli cell tumors given their higher metastatic potential